November 22, 2022
GlaxoSmithKline on November 21 launched a pediatric subcutaneous version of its asthma treatment Nucala (mepolizumab) in Japan as a new dosage form responding to the drug’s label expansion in 2020 for use in children aged six to 11. Nucala Solution...read more